期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
LC-MS/MS法测定人血浆中氟吡汀及其代谢产物D-13223浓度的不确定度评定 被引量:1
1
作者 刘艳芳 霍花 +3 位作者 李大兵 卢新阳 王童超 杨绍青 《中国药师》 CAS 2018年第9期1598-1603,共6页
目的:评价LC-MS/MS方法测定人血浆中氟吡汀及代谢产物D-13223浓度的不确定度。方法:对氟吡汀及代谢产物D-13223浓度测定过程中影响因素,包括重复性、称量、标准溶液配制、含药血浆配制、萃取过程、线性回归、仪器量化等进行分析评定和计... 目的:评价LC-MS/MS方法测定人血浆中氟吡汀及代谢产物D-13223浓度的不确定度。方法:对氟吡汀及代谢产物D-13223浓度测定过程中影响因素,包括重复性、称量、标准溶液配制、含药血浆配制、萃取过程、线性回归、仪器量化等进行分析评定和计算,根据各分量计算出合成不确定度并进行扩展。结果:置信概率P为95%时,人血浆中氟吡汀低、中、高浓度可表示为:(20.5±1.49),(200±14.4),(1 527±121)ng·ml-1;人血浆中D-13223低、中、高浓度可表示为:(3.93±0.34),(39.6±3.27),(301±24.5)ng·ml^(-1)。结论:本方法适用于LC-MS/MS法测定血浆中氟吡汀及代谢产物D-13223的不确定度评定,为复杂生物基质分析过程的不确定度评定提供了参考。 展开更多
关键词 氟吡汀 d-13223 高效液相色谱-质谱联用法 不确定度
原文传递
Quantification of flupirtine and its active metabolite D-13223 in human plasma by LC-MS/MS: application to a clinical trial of flupirtine maleate capsules in healthy male Chinese volunteers
2
作者 Yanfang Liu Jiashan Zhang +1 位作者 Yunbiao Tang Hua Huo 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第10期822-830,共9页
In the present study, we developed a simple, sensitive, precise, and accurate liquid chromatography-tandem mass spectrometric(LC-MS/MS) method and validated such approach for simultaneous determination of flupirtine a... In the present study, we developed a simple, sensitive, precise, and accurate liquid chromatography-tandem mass spectrometric(LC-MS/MS) method and validated such approach for simultaneous determination of flupirtine and its active metabolite D-13223 in human plasma. The flupirtine, D-13223, and stable isotope internal standard(IS) were extracted from plasma samples by liquid-liquid extraction and chromatographed on a C18 column with a mobile phase consisting of acetonitrile–water–ammonia(55:45:0.1, v/v/v) at a flow rate of 0.25 m L/min. Detection was performed on a triple quadrupole tandem mass spectrometer with an electrospray ionization source(ESI) by multiple reaction monitoring(MRM) in positive ion mode. The linear calibration curves were obtained within the concentration range of 10.00–2000.00 ng/m L for flupirtine and 2.00–400.00 ng/m L for D-13223. The intra-and inter-run RSD, calculated from quality control(QC) samples, was less than 9.26% for flupirtine and D-13223. The accuracy was –5.80%–3.31% for flupirtine and D-13223. The extraction recoveries of flupirtine, D-13223, and their IS were all between 88.3%–97.2%. The method was successfully applied to investigate the pharmacokinetic profiles of flupirtine and its active metabolite D-13223 in human plasma following peroral administration of 100 mg flupirtine maleate capsules in healthy male Chinese volunteers. 展开更多
关键词 FLUPIRTINE d-13223 LC-MS/MS Clinical trial
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部